confirmed by Walpole (see Matthews and Walpole, 1958) . Fairhall and Miller (1941) reported kidney changes (enlargment of cells, vesiculation of nuclei, and accumulation of brown granules) but no tumours, in rats fed diets containing 0-1 per cent lead arsenate or 0 I per cent lead carbonate for two years. Boyland, Dukes, Grover and Mitchley (1962) reported the induction of cuboidal cell carcinomas in rats fed a diet containing 1 per cent wt/wt (dry diet) lead acetate: 15 out of 16 rats which survived for 331 days or more, up to 629 days, developed single or multiple kidney tumours. Because it was known that lead compounds cause increased secretion of porphyrins, another compound, namely sedormid, having the same effect was administered in the diet to a second group of rats. The only kidney tumour recorded in this group, 17 of which survived for more than 300 days, was a small transitional-cell carcinoma of the renal pelvis. van Esch, van Genderen and Vink (1962) also induced renal tumours in rats of both sexes by feeding lead acetate. Thirteen out of 24 rats given 1 0 per cent, and 11 out of 32 given 0.1 per cent lead acetate in the diet developed renal neoplasms.
Testosterone has been shown to have a renotropic effect by several workers (Selye, 1939; Thorn and Engel, 1938; Korenchevsky and Hall, 1939) . Roe and Mitchley, (1962) reported that in female CBA mice, the administration of 1 mg. testosterone once weekly for 30 weeks caused (a) a reduction in body weight, (b) an increase in the kidney weight/body weight, kidney weight/liver weight, and kidney weight/heart + lung weight ratios up to, or above, the values normally found in male CBA mice. Klopp, Young and Taylor (1945) investigated, with negative result, the possibility that testosterone might benefit patients with renal failure.
Haddow (1954) reported that a single intraperitoneal injection of 10 mg. xanthopterin given to rats weighing about 150 g. gave rise to a dramatic increase in kidney size, accompanied by an outburst of mitotic activity in the renal tubules. Subsequently the same effect of xanthopterin was observed in mice, guinea-pigs, rabbits and hamsters.
The purpose of the experiment described in the present paper was to see whether the administration of testosterone or of xanthopterin to rats would influence renal carcinogenesis by lead.
MATERIALS AND METHODS
Two hundred male albino rats of the Chester Beatty strain were divided randomly into 10 groups (A-K) of 24 or 16 rats as shown in Table I . Throughout At first, all treatments were given by subcutaneous injection. Later (see Table I ) lead and xanthopterin were given by the intraperitoneal route because of inflammation of the body wall.
RESULTS

Kidney tumours
Kidney tumours arose in altogether 34 rats of Groups A, B, F, G and K. Details of their incidence and time of appearance are shown in Table II Table I) arising in the renal pelvis. Apart from these 2 control rats kidney tumours were only seen in rats given injections of lead phosphate at the two higher dose levels (L+++ and L++). No kidney tumours developed in groups given the lowest dose of lead phosphate (L+), either alone (Group C) or in combination with testosterone or xanthopterin (Groups D and E). Similarly, none arose in response to testosterone alone or xanthopterin alone. There was no evidence that testosterone or xanthopterin either increased or 'reduced the carcinogenic effect of the intermediate dose of lead phosphate on the kidney (c.f. Groups B, F and G).
One of the two neoplasms seen in the control group, i.e. the transitional cell carcinoma, was clearly of a different histological type from all the other tumours. The fact that one undifferentiated carcinoma of the renal cortex occurred in an animal which received no treatment may be taken as an indication that a low incidence of this type of tumour is to be expected as a " spontaneous " event in the strain of rats used for the experiment. The distinction between benign renal tumours and malignant renal tumours was not clear-cut except where distant metastases were present. Renal disease other than neoplasia Chronic nephritis of the type which gives rise to widespread distension of the renal tubules by eosinophilic hyaline material was present in almost all the rats of all groups. None of the treatments appeared to affect the severity of the condition (Table III) and it is notable that there was no obvious relation between its severity and tumour development in Groups B, F and G. kidneys of all rats killed between 401 and 500 days were put in random order. The chronic nephritic condition was then graded as " mild " or " severe " by one of us (F.J.C.R.) without knowledge of from which group the sections were derived. The condition was regarded as " mild " if tubular cysts and casts were few and there was no generalised enlargment of the kidnev. All other cases were regarded as " severe ". No unaffected kidneys were encountered.
In addition to the condition of chronic nephritis, which was common to all groups, all the kidneys from rats treated with xanthopterin contained crystalline deposits which were thought to be xanthopterin itself. These deposits were both within and between cells of the renal tubules. Their presence appeared to give rise to no inflammatory response and had no obvious effect either on the severity of the chronic nephritis or on the induction of renal tumours.
Incidence of non-renal tumours
This is shown in Table IV . Exposure to lead was not obviously associated with the development of tumours other than of the kidney.
DISCUSSION
Clearly the results of the experiment were essentially negative. Xanthopterin, in doses sufficient to give rise to crystalline deposits in the kidneys, did not Since chronic nephritis was present in all the rats in the experiment it is not possible to say whether its presence was necessary for tumour induction. However, this seems unlikely in so far as the severity of the nephritic condition bore no relation to the tumour response: kidneys showing severe nephritis had no tumours, despite exposure to lead, whilst tumours were present in kidneys only slightly affected by chronic nephritis. van Esch et al. (1962) in discussing the relationship between chronic nephritis and renal tumours, implied that lead administration gives rise to both lesions. Unfortunately, they do not give details of the occurrence of chronic nephritis in their control animals.
It is interesting that, at the lowest level of administration, lead phosphate injections gave rise to no renal neoplasms (Groups C, D and E). This suggests that, for practical purposes anyway, there is a threshold dose level (between 29 and 145 mg. lead phosphate per rat in the present experiment) below which renal -tumours are not induced.
In a follow-up study of 425 pensioners who had been previously exposed to lead in an accumulator factory Dingwall-Fordyce and Lane (1963) found "no evidence to suggest that malignant disease was associated with lead absorption ". There was an increase in the incidence of cerebrovascular catastrophies. The present experiments show that a large dose of lead is necessary to induce kidney tumours in rats. 3. All the rats in the experiment, including untreated controls, suffered mildly or severely from chronic nephritis. The administration of lead, xanthopterin or testosterone had no obvious effect on the severity of the renal disease, and the severity of the disease was not obviously associated with tumour development.
4. Primary neoplasms of sites other than the kidney arose in approximately equal frequency in all groups, and there was no indication that any of the chemical agents influenced their occurrence.
